Company / Working Capital
Century Therapeutics, Inc. Working Capital History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$100.5M
FY2025
5-year range
$64.3M / $289.9M
FY2022-FY2025
Trend
+56.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 2 years of decline, reaching $101M.
Based on SEC 10-K filings.
$101M in FY2025 with a 3-year CAGR of -29.7%.
Declined from $159M to $101M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -29.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -29.7%, indicating a declining trend.
- In FY2025, working capital increased 56.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $100.5M | +56.4% |
| FY2024 | $64.3M | -59.6% |
| FY2023 | $159.1M | -45.1% |
| FY2022 | $289.9M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026